| ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes | breast, |
| c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells. | breast, |
| Expression of the ets-1 proto-oncogene in human colorectal carcinoma. | colorectal, |
| Proto-oncogene Ets-1 and the kidney. | kidney, |
| Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma. | liver, |
| Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma. | sarcoma, |
| Glioma invasion--pattern of dissemination by mechanisms of invasion and surgical intervention, pattern of gene expression and its regulatory control by tumorsuppressor p53 and proto-oncogene ETS-1. | glioma, |
| Importance of ets1 proto-oncogene for breast cancer progression. | breast, |
| Expression of the ets-1 proto-oncogene in human breast carcinoma: differential expression with histological grading and growth pattern. | breast, |
| Histamine elevates the expression of Ets-1, a protooncogen in human melanoma cell lines through H2 receptor. | skin, |
| Modification of local protooncogene Ets-1 level is likely being involved in the regulation of melanoma growth | skin, |
| Expression of Ets-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas. | schwannomas,myoma, |
| Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9. | meningiomas, |
| TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. | prostate, |
| Kaposi s sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1. | sarcoma, |
| Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. | prostate, |
| Identification of distinct classes of ETS gene rearrangements demonstrates that dormant oncogenes can be activated in prostate cancer by juxtaposition to tissue-specific or ubiquitously active genomic loci. | prostate, |
| Ets-1 proto-oncogene as a potential predictor for poor prognosis of lung adenocarcinoma. | lung, |
| The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. | breast, |
| Renal expression of proto-oncogene Ets-1 on matrix remodeling in experimental diabetic nephropathy. | kidney, |